Business Context and Reporting Period
This Form 8-K Current Report, dated August 20, 2019, pertains to American Public Education, Inc. (APEI), a Delaware corporation. The filing announces a significant leadership transition within the company's executive management and Board of Directors.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and employment terms.
Material Changes
The primary material change is the appointment of Angela Selden as the new Chief Executive Officer (CEO), effective September 23, 2019. Concurrently, Dr. Wallace E. Boston will step down as CEO but will continue as President of American Public University System, Inc. (APUS) until his expected retirement in June 2020. Dr. Boston will also remain on the Board of Directors.
Management Commentary, Risks, and Unusual Items
Executive Compensation and Agreements
- Angela Selden (Incoming CEO):
- Base Salary: $630,000 annually.
- Signing Bonus: $100,000 (payable in two installments).
- Equity Grants: Restricted stock units valued at $1,400,000 and stock options with a grant date fair value of $600,000.
- Bonus Eligibility: Up to 90% of base salary plus an additional 45% for stretch goals. The 2019 bonus is prorated with a floor of $200,000 and a cap of $300,000.
- Severance: In the event of termination without Cause or for Good Reason, Ms. Selden is eligible for two times her annual salary and two times her annual bonus, plus 24 months of welfare benefits.
- Relocation: Up to $75,000 in expenses and up to $8,000 per month for temporary lodging for one year.
- Dr. Wallace E. Boston (Outgoing CEO):
- New Role: President of APUS (effective September 23, 2019).
- Base Salary: $500,000 annually.
- Bonus Eligibility: Up to 90% of base salary plus an additional 45% for stretch goals for 2019 and 2020.
- Severance: Upon termination (other than for Cause/Disability) or retirement, Dr. Boston is entitled to two times his 2019 base salary and two times his 2019 annual bonus, plus 24 months of welfare benefits.
- Equity: Outstanding equity awards will vest in full on the Retirement Date (June 30, 2020), subject to performance criteria for incomplete periods.
Risks and Contingencies
The filing notes that Ms. Selden is subject to indefinite confidentiality restrictions and 24-month post-termination non-competition and non-solicitation covenants. Dr. Boston has waived rights to terminate for Good Reason specifically related to his resignation as CEO.
Investor Verification Checklist
- Verify the exact transition date of September 23, 2019, for the change in CEO leadership.
- Review the full text of the Executive Employment Agreement (Exhibit 10.1) and Amended Employment Agreement (Exhibit 10.2) for specific definitions of "Cause," "Good Reason," and performance targets.
- Confirm the calculation methodology for the restricted stock units granted to Ms. Selden, which depends on the 60-day average closing price of APEI stock ending on the Transition Date.
- Monitor the company's subsequent filings for the actual vesting of Dr. Boston's equity awards upon his retirement in June 2020.